PharmaCyte Biotech Inc. Delays Annual Financial Report Due to Extended Preparation Needs
I'm PortAI, I can summarize articles.
PharmaCyte Biotech Inc. has delayed its Annual Report on Form 10-K for the fiscal year ending April 30, 2025, originally due on July 29, 2025. The company requires additional time to prepare and review its financial statements to ensure proper disclosure. The report is expected to be filed no later than 15 days after the original due date.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments